Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use

• Beryl Primrose Gladstone,

  Affiliation Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany

  ⨯
• Andrea Cona,

  Affiliations Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany, Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Milan, Italy

  ⨯
• Parichehr Shamsrizi,

  Affiliation Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany

  ⨯
• Tuba Vilken,

  Affiliation Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany

  ⨯
• Winfred V. Kern,

  Affiliation Infectious Diseases, Department of Medicine, University Hospital and Medical Center and Albert-Ludwigs-University Faculty of Medicine, Freiburg, Germany

  ⨯
• Nisar Malek,

  Affiliation Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany

  ⨯
• Evelina Tacconelli

  * E-mail: Evelina.Tacconelli@med.uni-tuebingen.de

  Affiliation Infectious Diseases, Department of Internal Medicine I, DZIF Partner, Tübingen University Hospital, Tübingen, Germany

  ⨯